NM_003221.4:c.92A>G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PP2PP3BS1_SupportingBS2

The NM_003221.4(TFAP2B):​c.92A>G​(p.Asp31Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000934 in 1,594,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000099 ( 0 hom. )

Consequence

TFAP2B
NM_003221.4 missense

Scores

9
8
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 9.23

Publications

0 publications found
Variant links:
Genes affected
TFAP2B (HGNC:11743): (transcription factor AP-2 beta) This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]
TFAP2B Gene-Disease associations (from GenCC):
  • Char syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, G2P
  • TFAP2B-related congenital heart disease spectrum disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • patent ductus arteriosus 2
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • familial patent arterial duct
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 8 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 1.2875 (below the threshold of 3.09). Trascript score misZ: 1.6268 (below the threshold of 3.09). GenCC associations: The gene is linked to familial patent arterial duct, Char syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.831
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000398 (6/150736) while in subpopulation NFE AF = 0.0000738 (5/67718). AF 95% confidence interval is 0.0000286. There are 0 homozygotes in GnomAd4. There are 4 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003221.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TFAP2B
NM_003221.4
MANE Select
c.92A>Gp.Asp31Gly
missense
Exon 2 of 7NP_003212.2Q92481-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TFAP2B
ENST00000393655.4
TSL:1 MANE Select
c.92A>Gp.Asp31Gly
missense
Exon 2 of 7ENSP00000377265.2Q92481-1
TFAP2B
ENST00000344788.7
TSL:3
c.86A>Gp.Asp29Gly
missense
Exon 3 of 4ENSP00000342252.3X6R4Y8
TFAP2B
ENST00000489228.1
TSL:2
n.387A>G
non_coding_transcript_exon
Exon 2 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000398
AC:
6
AN:
150736
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000245
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000738
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000187
AC:
4
AN:
214320
AF XY:
0.0000344
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000428
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000990
AC:
143
AN:
1444132
Hom.:
0
Cov.:
33
AF XY:
0.0000977
AC XY:
70
AN XY:
716662
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32948
American (AMR)
AF:
0.00
AC:
0
AN:
42284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25676
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38458
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83668
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5574
European-Non Finnish (NFE)
AF:
0.000126
AC:
139
AN:
1103782
Other (OTH)
AF:
0.0000670
AC:
4
AN:
59680
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000398
AC:
6
AN:
150736
Hom.:
0
Cov.:
31
AF XY:
0.0000544
AC XY:
4
AN XY:
73540
show subpopulations
African (AFR)
AF:
0.0000245
AC:
1
AN:
40858
American (AMR)
AF:
0.00
AC:
0
AN:
15148
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5074
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4722
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10452
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000738
AC:
5
AN:
67718
Other (OTH)
AF:
0.00
AC:
0
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.00000828
AC:
1

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Char syndrome (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.27
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.76
D
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.14
D
MetaRNN
Pathogenic
0.83
D
MetaSVM
Uncertain
0.41
D
MutationAssessor
Uncertain
2.7
M
PhyloP100
9.2
PrimateAI
Uncertain
0.73
T
PROVEAN
Pathogenic
-5.6
D
REVEL
Pathogenic
0.90
Sift
Uncertain
0.0010
D
Sift4G
Benign
0.19
T
Polyphen
0.99
D
Vest4
0.67
MutPred
0.51
Loss of solvent accessibility (P = 0.1177)
MVP
0.90
MPC
0.93
ClinPred
0.95
D
GERP RS
5.3
Varity_R
0.64
gMVP
0.63
Mutation Taster
=25/75
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752548154; hg19: chr6-50791130; API